Infectious Disease Frontier Archives - Page 8 of 35

Insights from Dr. Khalil Ghanem on the Challenges and Future of Syphilis Diagnosis, Treatment, and Prevention

By Ren Jiamo 2024.10.15

Editor's Note: As the incidence of syphilis continues to rise, clinicians are faced with an increasing number of patients with complex clinical presentations, posing significant challenges in patient management. At…

Application of carbapenems in the treatment of MDR-GNB and management of drug resistance

By Mourabit Halima 2024.10.15

Editor's note: With the increase in multi-drug resistant Gram-negative bacterial infections (MDR-GNB) worldwide, the use strategy of carbapenems as key drugs for the treatment of such infections has received widespread…

AIDS Exclusive Interview | AMP Trial: Successes and Breakthroughs in HIV Prevention

By Peng Longmei 2024.10.14

Editor's Note: The breakthrough results from the Antibody Mediated Prevention (AMP) trials have revitalized global public health efforts in the field of HIV prevention. At the AIDS 2024 conference, Dr.…

AIDS Interview | HIV Vaccine: Where Are We Now, and What Does the Future Hold?

By Ren Jiamo 2024.10.14

Editor's Note: In the global fight against AIDS, the development of an HIV vaccine has always been a focal point of attention. Recently, Dr. Devin Sok, Vice President of the…

Dr. Hongzhou Lu: Driving High-Quality Development in Infectious Disease Prevention with Innovative Productivity at the 15th Tuberculosis Oriental Forum

By Peng Longmei 2024.10.12

Editor’s Note: Innovation is the primary driving force for development and a key component of new quality productivity that the nation is advocating. In medicine, particularly in preventing and treating…

Dr. Shuihua Lu: Expanding from Tuberculosis-Free Communities to Tuberculosis-Free Cities with the Power of Technology丨15th Tuberculosis Eastern Forum

By Mourabit Halima 2024.10.09

Editor's Note: The convergence of innovation and knowledge flows through Shenzhen, a city in the Greater Bay Area. The "2024 Annual Meeting of the National Clinical Research Center for Infectious…

Shitong Huan: Improving Health Systems and Innovating Diagnostic and Treatment Tools to Eliminate Tuberculosis丨15th Tuberculosis Eastern Forum

By Mourabit Halima 2024.10.08

Editor's Note: Humanity has coexisted with tuberculosis for over 5,000 years. It claimed the lives of renowned figures like Shelley, Empress Sisi, and Lu Xun. Ending the "white plague" is…

99.9% HIV-Free! Lenacapavir Shows Outstanding Results in Long-Acting PrEP Trial

By Mourabit Halima 2024.09.24

Editor’s Note: On September 12, Gilead Sciences announced promising interim results from a pivotal Phase III trial evaluating the efficacy of Lenacapavir, a twice-yearly injectable HIV-1 capsid inhibitor, for the…

CCML 2024丨Dr. Xiaoling Ma: Setting Standards, Leveraging Technology, and Advancing Clinical Microbiology Testing Quality Across China

By El Bachir MOURABIT 2024.09.23

Editor’s Note: The 2024 Annual Academic Conference of the Clinical Microbiology Laboratory Committee (CCML 2024), organized by the Chinese Hospital Association and the Clinical Microbiology Laboratory Professional Committee, was held…

Dr. Yonghong Xiao: Responsibilities and Capacity Building of Infectious Disease Physicians

By Lisa Cui 2024.09.22

Editor's Note: In China, the Infectious Diseases Department has existed as an independent clinical department for over half a century, with the primary responsibility of infectious disease physicians being the…